Overview

A Study in People With Mild Hypertension

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to test the hypothesis that LY518674, administered for 6 weeks to patients with mild hypertension, reduces Systolic Blood Pressure, compared with placebo.

Phase:

Phase 2

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Hydrochlorothiazide